Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;83(3):381-412.
doi: 10.1016/j.jinf.2021.06.017. Epub 2021 Jun 20.

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers

Affiliations
Comment

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers

Marie Tré-Hardy et al. J Infect. 2021 Sep.
No abstract available

Keywords: Covid-19; Efficacy; Immunogenicity; SARS-CoV-2; mRNA-1273 vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Competing Interest The authors have no relevant competing interest to disclose in relation to this work.

Figures

Fig 1
Fig. 1
Antibody responses in seronegative (A) and seropositive (B) HCWs after mRNA-1273 vaccination. It shows the titers of SARS-CoV-2 IgG antibodies directed against the subunits (S1) and (S2) of the virus spike protein before (T0), 2 weeks after the first injection (T1), 2 weeks after the second injection (T2) and 3 months after the first infection (T3) according to the participant serological status (n = 205). The Box-and-Whisker plot represents the 25th and 75th percentiles. Inside the box, the horizontal line indicates the median (the 50th percentile). Discs in light grey represent far out values. A Wilcoxon test was used to assess the changes in IgG levels between T0, T1, T2 and T3 times within seronegative (n = 161) and seropositive subjects (n = 44). A P-value < 0.05 was considered significant.

Comment in

Comment on

References

    1. Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, et al. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG. J Infect. 2021 doi: 10.1016/j.jinf.2021.05.023. - DOI - PMC - PubMed
    1. Meyer B. Waning antibodies to SARS-CoV-2 - Don't panic. Lancet Reg Health Eur. 2021;4 doi: 10.1016/j.lanepe.2021.100115. - DOI - PMC - PubMed
    1. Doria-Rose N, Suthar MS, Makowski M, O'Connell S, McDermott AB, Flach B, et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med. 2021 doi: 10.1056/NEJMc2103916. - DOI - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Wu K, Werner AP, Koch M, Choi A, Narayanan E, Stewart-Jones GBE, et al. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine. N Engl J Med. 2021;384(15):1468–1470. doi: 10.1056/NEJMc2102179. - DOI - PMC - PubMed